Potassium-competitive Acid Blockers: A New Therapeutic Strategy for Helicobacter pylori Eradication
The escalating prevalence of clarithromycin resistance in cases of Helicobacter pylori, insufficient acid suppression, and pharmacodynamic variations secondary to inter-individual differences in CYP2C19 polymorphism collectively contribute to suboptimal eradication rates observed with proton pump in...
Saved in:
Main Authors: | Byeong Yun Ahn (Author), Soo-Jeong Cho (Author) |
---|---|
Format: | Book |
Published: |
Yong Chan Lee,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Potassium-Competitive Acid Blockers in Helicobacter pylori Eradication
by: Jong Kyu Park
Published: (2017) -
Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related Disorders
by: Mun Young Cho, et al.
Published: (2023) -
Potassium-competitive acid blocker-associated gastric mucosal lesions
by: Kimitoshi Kubo, et al.
Published: (2024) -
Helicobacter pylori Eradication Rate in Patients with Diabetes
by: Jiyeon Yoo, et al.
Published: (2017) -
Can Gastric Helicobacter Pylori Eradication Increase by Eradication of Oral Helicobacter Pylori by Periodontal Treatment? Literature Review
by: Ayla ÖZTÜRK
Published: (2023)